Radiomics-based Artificial Intelligence System to Predict Neoadjuvant Treatment Response in Rectal Cancer

2020 ◽  
Author(s):  
Keyword(s):  
Artificial Intelligence ◽  
Rectal Cancer ◽  
Treatment Response ◽  
Neoadjuvant Treatment ◽  
Artificial Intelligence System ◽  
Intelligence System

scholarly journals B-PO03-101 ABLATION DELIVERY PARAMETERS PREDICT IMPEDANCE DECREASE DURING ATRIAL FIBRILLATION ABLATION VIA A CLOUD ARTIFICIAL INTELLIGENCE SYSTEM ANALYSIS

Heart Rhythm ◽  
2021 ◽  
Vol 18 (8) ◽  
pp. S229-S230
Author(s):  
Clinton J. Thurber ◽  
John Whitaker ◽  
Omar Kreidieh ◽  
Ahmad Halawa ◽  
Parinita A. Dherange ◽  
...  
Keyword(s):  
Artificial Intelligence ◽  
Atrial Fibrillation ◽  
System Analysis ◽  
Atrial Fibrillation Ablation ◽  
Artificial Intelligence System ◽  
Intelligence System

330 DEVELOPMENT AND VALIDATION OF AN ARTIFICIAL INTELLIGENCE SYSTEM TO OPTIMIZE CLINICIAN REVIEW OF PATIENT RECORDS

2021 ◽  
Vol 160 (6) ◽  
pp. S-64-S-65
Author(s):  
Ethan A. Chi ◽  
Gordon Chi ◽  
Cheuk To Tsui ◽  
Yan Jiang ◽  
Karolin Jarr ◽  
...  
Keyword(s):  
Artificial Intelligence ◽  
Patient Records ◽  
Artificial Intelligence System ◽  
Intelligence System ◽  
Development And Validation

scholarly journals MRI-based clinical-radiomics model predicts tumor response before treatment in locally advanced rectal cancer

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Andrea Delli Pizzi ◽  
Antonio Maria Chiarelli ◽  
Piero Chiacchiaretta ◽  
Martina d’Annibale ◽  
Pierpaolo Croce ◽  
...  
Keyword(s):  
Machine Learning ◽  
Rectal Cancer ◽  
Treatment Response ◽  
Randomized Clinical Trials ◽  
Locally Advanced ◽  
Neoadjuvant Treatment ◽  
Learning Model ◽  
Partial Least Square ◽  
Machine Learning Model ◽  
Pre Treatment

AbstractNeoadjuvant chemo-radiotherapy (CRT) followed by total mesorectal excision (TME) represents the standard treatment for patients with locally advanced (≥ T3 or N+) rectal cancer (LARC). Approximately 15% of patients with LARC shows a complete response after CRT. The use of pre-treatment MRI as predictive biomarker could help to increase the chance of organ preservation by tailoring the neoadjuvant treatment. We present a novel machine learning model combining pre-treatment MRI-based clinical and radiomic features for the early prediction of treatment response in LARC patients. MRI scans (3.0 T, T2-weighted) of 72 patients with LARC were included. Two readers independently segmented each tumor. Radiomic features were extracted from both the “tumor core” (TC) and the “tumor border” (TB). Partial least square (PLS) regression was used as the multivariate, machine learning, algorithm of choice and leave-one-out nested cross-validation was used to optimize hyperparameters of the PLS. The MRI-Based “clinical-radiomic” machine learning model properly predicted the treatment response (AUC = 0.793, p = 5.6 × 10–5). Importantly, the prediction improved when combining MRI-based clinical features and radiomic features, the latter extracted from both TC and TB. Prospective validation studies in randomized clinical trials are warranted to better define the role of radiomics in the development of rectal cancer precision medicine.

scholarly journals COVID-19-induced vascular angiopathy: CTPA signs in critically ill patients other than acute pulmonary embolism and high-lung opacity scores

2021 ◽  
Vol 52 (1) ◽  
Author(s):  
Mohamed Hossameldin khalifa ◽  
Ahmed Samir ◽  
Ayman Ibrahim Baess ◽  
Sara Samy Hendawi
Keyword(s):  
Artificial Intelligence ◽  
Pulmonary Embolism ◽  
Lung Volume ◽  
Acute Pulmonary Embolism ◽  
Pulmonary Angiography ◽  
Vascular Tree ◽  
Ct Pulmonary Angiography ◽  
Artificial Intelligence System ◽  
Intelligence System ◽  
Severity Scores

Abstract Background Vascular angiopathy is suggested to be the major cause of silent hypoxia among COVID-19 patients without severe parenchymal involvement. However, pulmonologists and clinicians in intensive care units become confused when they encounter acute respiratory deterioration with neither severe parenchymal lung involvement nor acute pulmonary embolism. Other radiological vascular signs might solve this confusion. This study investigated other indirect vascular angiopathy signs on CT pulmonary angiography (CTPA) and involved a novel statistical analysis that was performed to determine the significance of associations between these signs and the CT opacity score of the pathological lung volume, which is calculated by an artificial intelligence system. Results The study was conducted retrospectively, during September and October 2020, on 73 patients with critical COVID-19 who were admitted to the ICU with progressive dyspnea and low O2 saturation on room air (PaO2 < 93%). They included 53 males and 20 females (73%:27%), and their age ranged from 18 to 88 years (mean ± SD=53.3 ± 13.5). CT-pulmonary angiography was performed for all patients, and an artificial intelligence system was utilized to quantitatively assess the diseased lung volume. The radiological data were analyzed by three expert consultant radiologists to reach consensus. A low CT opacity score (≤10) was found in 18 patients (24.7%), while a high CT opacity score (>10) was found in 55 patients (75.3%). Pulmonary embolism was found in 24 patients (32.9%); three of them had low CT opacity scores. Four other indirect vasculopathy CTPA signs were identified: (1) pulmonary vascular enlargement (57 patients—78.1%), (2) pulmonary hypertension (14 patients—19.2%), (3) vascular tree-in-bud pattern (10 patients—13.7%), and (4) pulmonary infarction (three patients—4.1%). There were no significant associations between these signs and the CT opacity score (0.3205–0.7551, all >0.05). Furthermore, both pulmonary vascular enlargement and the vascular tree-in-bud sign were found in patients without pulmonary embolism and low CT-severity scores (13/15–86.7% and 2/15–13.3%, respectively). Conclusion Pulmonary vascular enlargement or, less commonly, vascular tree-in-bud pattern are both indirect vascular angiopathy signs on CTPA that can explain the respiratory deterioration which complicates COVID-19 in the absence of severe parenchymal involvement or acute pulmonary embolism.

Sign in / Sign up

Export Citation Format

Share Document